Emulate raised $12 million from four financial backers on July 11th according to information disclosed by the company. The non-brokered equity offering was fully subscribed. No offering was previously initiated by the company under a registration exemption with the SEC.
Emulate commercializes an automated ‘Organs-on-Chips’ platform that mimics human physiology and diseases, while permitting real-time elucidation of molecular mechanisms of action and toxicity. The company is backed by NanoDimension, Cedars-Sinai Medical Center and private investor Hansjörg Wyss.
The company was registered in 2013 and has its headquarters located in Cambridge MA. Emulate elected to keep its revenues undisclosed.
The executive team includes Daniel Levner, David James Coon, Geraldine A Hamilton and Gregory D Williams.
The board of directors includes Eric Moessinger and Hansjoerg Wyss.
Amount offered: $12 million
Amount placed: $12 million
First sale: 07-11-2014
Data as of: 07-28-2014
For more information visit www.XDATA.co